Program areas at MSKCC
Patient care: Memorial Sloan-Kettering Cancer Center experts have established standards of care and treatment protocols for each type and stage of Cancer. Our physicians have an extraordinary depth and breadth of experience in diagnosing and treating all forms of the disease, from the most common to the very rare. Each year, they treat more than 400 different subtypes of Cancer. This level of specialization can have an often-dramatic effect on a patient's chances for a cure or control of their Cancer. While we are known for our advanced, innovative therapies, our physicians are equally well regarded for their compassion and concern. Our disease management program features 16 multidisciplinary Cancer teams. Patients are treated by as many different specialists as are needed for their particular type of disease, including surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, psychiatrists, and nurses. Our pathologists have unsurpassed expertise in using advanced methods to accurately diagnose Cancer. Because of their sole focus on Cancer, our surgeons use surgical techniques that preserve form and function. Our radiation oncologists are developing and putting into clinical practice leading-edge technologies and techniques in radiation therapy. In addition, the Center offers a full range of programs to help patients and families throughout all phases of treatment, including support groups, genetic counseling, help managing Cancer pain and symptoms, rehabilitation, integrative medicine services, and assistance in navigating life after treatment. Throughout the covid-19 pandemic and beyond mskcc continues to work to protect and assist the public. Currently, the institution is actively maintaining a posture of prevention and safety, with its education programs while encouraging persons to wear their masks and adhere to other preventive measures like getting booster shots.
Education: education is a vital part of Memorial Sloan-Kettering Cancer Center's mission. Our training programs prepare physicians and scientists for careers in the biomedical sciences. Our collaborations with the rockefeller university, cornell university, and weill medical college of cornell university offer phd programs in chemical biology, computational biology and medicine, and the medical sciences. The Center also partners with weill medical college and the rockefeller university to offer a md/phd degree for aspiring physician-scientists. The Center has a phd program in Cancer biology through its louis v. gerstner, jr. graduate school of biomedical sciences. This novel program has been enrolling students since 2006 and trains basic laboratory scientists to work in research areas directly relevant to Cancer and other human diseases. We also offer postgraduate clinical fellowships to train physicians who seek special expertise in a particular type of Cancer and postgraduate research fellowships that provide physicians and scientists with advanced laboratory research training. With faculty appointments at the weill medical college of cornell university, our clinical staff also train residents and medical students.
Research: Memorial Sloan-Kettering Cancer Center maintains one of the world's most dynamic programs of Cancer research. The extraordinary patient care we provide benefits from our innovative programs in basic, translational, and clinical research. Research at Sloan-Kettering institute is dedicated to understanding the biology of Cancer through programs in cell biology, genetics, biochemistry, molecular biology, structural biology, computational biology, immunology, and therapeutics. Investigators at Sloan-Kettering institute collaborate with Memorial hospital physician-scientists, a partnership that helps speed important research findings from the laboratory to the bedside, in a process known as translational research. Memorial Sloan-Kettering Cancer Center also actively initiates and participates in clinical trials to identify more effective Cancer therapies, and our physicians are currently leading more than 1,900 clinical trials for pediatric and adult cancers. The human oncology and pathogenesis program (hopp) is a further effort to increase institutional research strength in areas important in contemporary translational research. Hopp is designed to meld even more thoroughly the cultures of basic biologic science and clinical oncology, augmenting the work conducted in the laboratories of Memorial Sloan-Kettering Cancer Center's physician-scientists.